Johnson & Johnson's revenue was $94.2 billion for fiscal year 2025 (the twelve months to 28 Dec 2025), up 6.0% from fiscal 2024.
In the third quarter of fiscal 2026 (the three months to 27 Sep 2026) it was $25.4 billion, up 5.9% from a year earlier.
Over the four quarters to 27 Sep 2026, revenue was $99.3 billion.
From Johnson & Johnson's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 21 Oct 2026.
Fiscal 2025
$94.2B
+6.0%
Q3 FY2026
$25.4B
+5.9% on a year
Growth over 9 years
+3.0%
a year, FY 2016–FY 2025
Revenue by fiscal year
Change on the year before, under each year. From FY 2016 to FY 2025, Johnson & Johnson's revenue went from $71.9 billion to $94.2 billion, a compound annual change of +3.0%; FY 2025 is the highest of the period.
Johnson & Johnson revenue, fiscal years
Period
FY 2016
FY 2017
FY 2018
FY 2019
FY 2020
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Revenue
$71.9B
$76.5B
$81.6B
$82.1B
$82.6B
$78.7B
$80.0B
$85.2B
$88.8B
$94.2B
Period end
1 Jan 2017
31 Dec 2017
30 Dec 2018
29 Dec 2019
3 Jan 2021
2 Jan 2022
1 Jan 2023
31 Dec 2023
29 Dec 2024
28 Dec 2025
Revenue by quarter
The last eight fiscal quarters. Each is compared with the same quarter a year earlier on the company's page.
Revenue is the total amount a company earns from its sales of goods and services in a period, before any cost is deducted, as reported on its income statement. For banks it is net revenue: net interest income plus fees and other income. Figures are read from the report the company filed and checked against accounting identities; one that does not pass is left blank rather than estimated. See data and methodology.
Johnson & Johnson's other figures
Revenue of comparable companies
Everything on JNJ, in the terminal.
Twenty years of history, operating KPIs and segments, guidance against results, valuation, insiders and holders, charts and alerts.